These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Standard Operating Procedures for clinical trials of the CESAR Central European Society for Anticancer Drug Research--EWIV. Preface. Gastl G; Dittrich C Onkologie; 2003 Oct; 26 Suppl 6():IX. PubMed ID: 23570176 [No Abstract] [Full Text] [Related]
11. [Preclinical data as basis for the design of clinical studies]. Fichtner I Onkologie; 2008; 31 Suppl 2():34-8. PubMed ID: 18487867 [TBL] [Abstract][Full Text] [Related]
16. The pharmaceutical industry and oncology in central and eastern Europe. Ben-Am M; Gemperli B; Covelli A; Burke G Ann Oncol; 1999; 10 Suppl 6():15-7. PubMed ID: 10676548 [TBL] [Abstract][Full Text] [Related]
18. Legal considerations in clinical cancer research. Robertson JA Semin Oncol; 1981 Dec; 8(4):442-6. PubMed ID: 7323817 [No Abstract] [Full Text] [Related]
19. Improving the evaluation of new cancer treatments: challenges and opportunities. Rothenberg ML; Carbone DP; Johnson DH Nat Rev Cancer; 2003 Apr; 3(4):303-9. PubMed ID: 12671669 [TBL] [Abstract][Full Text] [Related]
20. An FDA oncology view of juvenile animal studies in support of initial pediatric trials for anticancer drugs. Leighton JK; Saber H; Reaman G; Pazdur R Regul Toxicol Pharmacol; 2016 Aug; 79():142-143. PubMed ID: 26952647 [No Abstract] [Full Text] [Related] [Next] [New Search]